N/A N=2,029 Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
Colorectal Cancer
Primary: Colorectal Cancer Screening by Study Arm — 205; 165; 32 Participants — p=0.04
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=646 Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations
Amyloid Cardiomyopathy, Transthyretin-Related
Primary: Prevalence of Transthyretin Cardiac Amyloidosis (ATTR-CA) in Cohort of Caribbean Hispanics and Blacks With Heart Failure (HF) — 7.8; 0 percentage of participants
N/A N=54 The Clinical Referral to Activity Study
Physical Inactivity · Cardiovascular Risk Factor · Obesity
Primary: Change From Baseline in Meeting the Aerobic Activity Goal at 12 Months — 14; 18; 11; 14 Participants — p=0.63
N/A N=62 Investigation of Strategies to Reduce the Impact of the Relative Age Effect in Kindergarten
Attention Deficit Hyperactivity Disorder
Primary: Disruptive Behavior Disorders Rating Scale — .8; 1.12; 1.03; 1.33 score on the scale
Phase 4 N=13 ED-Initiated School-based Asthma Medication Supervision
Asthma · Asthma in Children
Primary: 90-day Emergency Department (ED) Recidivism — 1; 2 Participants
Phase 2 N=20 Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
Advanced Head and Neck Squamous Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma · Metastatic Head-and-neck Squamous-cell Carcinoma
Primary: Overall Response - — 40.0 percentage of participants
Phase 4 N=786 Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
Opioid Use · Pain, Postoperative
Primary: Total 30 Day Post-discharge Home Opioid Use (Number of Tablets) — 10.00; 10.00; 6.18; 6.67 tablets — p=0.970
Phase 3 N=15 A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)
Chronic Spontaneous Urticaria
Primary: Serum Concentration of Dupilumab at Weeks 12 and 24 — 67700; 105000; 45800; 91600 nanogram/milliliter
Phase 2 N=21 Cabozantinib and Pembrolizumab in Metastatic Pancreas
Pancreatic Cancer
Primary: Progression-free Survival — 2 Participants
N/A N=19 Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM
HIV · Minority Stress · Mental Health Wellness 1
Primary: Feasibility of Online Mindfulness-Based Queer Resilience as Measured by Recruitment Rates — 19 Participants
N/A N=416 Flares of Low Back Pain With Activity Research Study
Low Back Pain
Primary: Participant-reported "Flares" of Low Back Pain (Aim 1) — 7.3 Mean flares per year
N/A N=199 Caregiver Self-Management of Stress
Caregiver Distress · Job Stress
Primary: 10-item Kessler Psychological Distress Scale (K10) — 23.38; 23.79 score on a scale — p=0.513
Phase 1 N=64 Study to Assess PDM608 in Healthy Adult Subjects
Parkinson Disease
Primary: Number of Participants With Adverse Events — 0; 0; 0; 0 Participants
N/A N=17 E-cigarettes for Harm Reduction in Adults With Asthma
Smoking · Asthma · Electronic Cigarette Use
Primary: Change in Cigarettes Per Day From Baseline to Week 8 and Week 16 — 16.34; 15.39; 9.51; 8.66 cigarettes per day — p=.004
Phase 2 N=22 A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)
Cystic Fibrosis · Bronchiectasis
Primary: Occurrence of Any Treatment Emergent Adverse Events — 85.7; 93.3 Percentage of participants